AzTrials
AzTrials

Emotional ProblemMindMyMindFUNCT04804917

3-year Follow-up of the Mind My Mind RCT

An observational study of Emotional Problem and Anxiety Disorder of Childhood, run by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a three-year follow up of a previously completed randomized clinical trial (RCT) of a transdiagnostic cognitive and behavioral (CBT) program ("Mind My Mind" [MMM]) compared to management as usual (MAU) in youth with emotional and behavioral problems. Read more about this study

Who is it for?
Ages 8 to 20 years
How many people
396 participants
Where
1 siteDenmark
Study dates
22 Mar 2021to 17 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 20 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: The study subjects are the 396 school-aged youths who were identified with indicated need for treatment of anxiety, depressive symptoms, and/or behavioral disturbances and randomized to MMM (n=197) or MAU (n=199). The parent of each of subject will be invited to answer questionnaires to assess the long-term outcomes. We will also follow the help-seeking population (n=573) and the age-matched background population in the four municipalities (study sites) by use of data drawn from the Danish National Registries (reference groups).

Who may be able to join

  • Participation in the Mind My Mind RCT (n=396)
  • Written consent by the parent and legal guardian to take part in the 3-year follow-up of the Mind My Mind RCT by answering the web-based questionnaires

Who cannot join

  • 1) Withdrawal from the follow-up of Mind My Mind RCT (n=63).

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Mental Health Services in the Capital Region, Denmark

    Copenhagen, DK-2900

Other trials in Denmark

About this study

Official title: Long-term Outcome of a Transdiagnostic Cognitive-behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: a 3-year Follow-up of a Randomized Clinical Trial

This is a three-year follow up of a previously completed randomized clinical trial (RCT) of a transdiagnostic cognitive and behavioral (CBT) program ("Mind My Mind" [MMM]) compared to management as usual (MAU) in youth with emotional and behavioral problems.

The effectiveness trial (Clinical Trials Identifier: NCT03535805) evaluated an intervention for help-seeking youth with emotional and behavioral health problems below the threshold for referral to specialized treatment. The experimental intervention MMM consisted of 9-13 weekly, individual therapy sessions delivered by psychologists in a non-specialist school-based setting. The CBT-methods were organized in modules for anxiety, depression and/or behavioral problems, and the therapy was completed within 17 weeks. The MAU was enhanced by two care-coordination visits to help coordinate the usual care in the four municipalities in Denmark. The trial was conducted in four diverse municipalities in Denmark.

Read more

The aim of this study is to determine the long-term effects of the transdiagnostic, modular CBT program ("Mind My Mind" [MMM]) compared to management as usual (MAU).

The three-year follow-up of the RCT of MMM versus MAU is nested in a larger study of help-seeking youth screened for eligibility and stratified into three groups with increasing severity of problems. Youths with an intermediate level of problems were included in the RCT. We screened 573 help-seeking youths, and we included and randomized a total of 396 youths (age 6-16 years, with anxiety, depressive symptoms, and/or behavioral problems) to MMM (n=197) or MAU (n=199).

The study participants comprise the 396 youths and their parents who participated in the RCT. We will use the help-seeking population and the background population in the four municipalities as reference groups.

The follow-up study does not include an intervention. The long-term outcome of MMM versus MAU will be investigated using parent-reported questionnaires administered in average three years after random allocation to intervention. All study participants are followed in the Danish national registries.

Read the detailed description

Background: Behavioral and cognitive-behavioral therapy (CBT) programs targeting a single class of problems are effective, however, these interventions have not been widely implemented, and the population of youth with common mental health problems is markedly undertreated. This knowledge-practice gap calls for pragmatic trials testing the long-term effectiveness of scalable interventions for common mental health problems among youth.

Objective: This is a three-year follow up of a previously completed, randomized clinical trial (RCT) of a transdiagnostic cognitive and behavioral (CBT) program ("Mind My Mind" [MMM]) compared to management as usual (MAU) in youth with emotional and behavioral problems. The RCT (Clinical Trials Identifier: NCT03535805) evaluated a scalable, transdiagnostic intervention for help-seeking youth with emotional and behavioral health problems below the threshold for referral to specialized mental health services.

The specific aim of this follow-up study is to determine the long-term effects of the transdiagnostic and modular CBT program ("Mind My Mind" [MMM]) compared to management as usual (MAU). The secondary aim is to conduct a cost-effectiveness analysis of MMM versus MAU.

Design: This long-term follow-up of the MMM versus MAU is nested in a larger observational study of the population of help-seeking youths who were screened for eligibility. We used a stage-based approach to identify youths with mental health problems requiring an intervention and to stratify the youths into three groups with increasing severity of problems. The youth with an intermediate level of emotional and behavioral problems were included in the RCT. The long-term outcome of the two comparison groups in the RCT will be investigated by administration of research questionnaires to the parents, and the total study population will be described by use of register-based data. The combined use of questionnaires and register-based data will minimize problems of attrition.

Setting: Non-specialist school-based settings in four municipalities in Denmark.

Participants: In summary, 573 help-seeking youths (age 6-16 years) and their parents took part in the screening. Seventy-five (13%) had mental health problems below the intervention threshold, 396 (69%) were deemed eligible for the early intervention and included in the RCT, and 52 (9%) had symptoms of severe mental health problems and disorders and were referred to specialized services. Fifty (9%) youth were excluded for other reasons. A total of 396 youths were identified with anxiety, depressive symptoms, and/or behavioral disturbances. This group was included in the RCT and randomized to MMM (n=197) or MAU (n=199). The primary outcome was the impact of mental health problems reported by the parent at week 18, using the Strengths and Difficulties Questionnaire (SDQ) impact scale (range=0-10 points).

The study participants comprise the 396 youths and their parents who participated in the RCT. We will use the help-seeking population and the background population in the four municipalities as reference groups.

Interventions: The follow-up study does not include an intervention. The MMM consisted of 9-13 weekly, individual therapy sessions delivered by local psychologists who received education and weekly supervision in the MMM manual. The CBT methods were organized in modules for anxiety, depression and behavioral problems. Flowcharts described the sequencing and dosing of modules to match the problems at hand, e.g. parent management training for youth's behavioral problems. The therapy was completed within 17 weeks, followed by a booster session after four weeks.

The MAU was enhanced by two care-coordination visits (week 2 and 17) to help access care in the municipality. The MAU interventions included anonymous counseling, pedagogical advice, network meetings, educational support, private or publicly funded psychological treatment, or no treatment.

Outcomes: The long-term outcome of MMM versus MAU will be investigated using parent-reported questionnaires administered in average three years after random allocation to intervention. All study participants are followed in the Danish national registries by linking of individual-level data from several registries. The follow-up will be conducted approximately three years (30-43 months) after the random allocation to intervention in the RCT.

The register-based exploratory outcomes will focus on the youth's use of psychiatric and somatic health care services, academic performance on the national school tests and exams, school absence and wellbeing in school. Regarding use of health care services, we will study the time to the first contact, and the frequency and the pattern of contacts (acute/non-acute, inpatient/outpatient, psychiatric/somatic) during the follow-up period. We will also track activities in the social sector including notifications to the authorities stating a concern for the health and wellbeing of the young person, and preventative interventions to assist the family. Finally, we will study changes in the parents' employment status (including sick leave, part-time work and unemployment) during the follow-up period to assess whether the participation in MMM, relatively to MAU, did influence the life circumstances of the family in a broader sense.

Cost-effectiveness analysis: The evaluation of the cost-effectiveness of the MMM, relative to MAU, will build on our previous cost-utility analysis (CUA) of data from the RCT. The extended follow-up time will reduce the uncertainty around the results by replacing the extrapolation scenarios with repeated assessment of the health-related quality of life measured with the parent-reported questionnaire CHU9D. The analyses of costs will include register-based, individual-level data on the young person's health care utilization in the 3-year follow-up period from the date of randomization, along with the associated unit costs that are listed in administrative registers.

Perspectives: The study will provide new knowledge of the long-term effectiveness of transdiagnostic CBT to lower the burden of mental health disorders in youth.

Keywords
Cognitive Behavioral Therapy, Long-term follow-up of RCT, Effectiveness, Transdiagnostic, Children, Adolescents, Youths, Indicated prevention, Personalized treatment
Medical subject headings
Depression, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04804917
Study groupRoleWhat they receive
Participants in the MindMyMind RCTThe study participants comprise the 396 youths (and their parents) who participated in the Mind My Mind RCT. The study participants were randomized to the experimental MMM intervention (n=197) or MAU (n=199) and followed in the trial until 26 weeks after randomization, from September 7, 2017, to August 28, 2019. The MMM consisted of 9-13 weekly, individual therapy sessions. The CBT methods were organized in modules for anxiety, depression and behavioral problems. Flowcharts described the sequencing and dosing of modules to match the problems at hand. The therapy was completed within 17 weeks, followed by a booster session after four weeks. The MAU was enhanced by two care-coordination visits (week 2 and 17). The MAU interventions included anonymous counseling, pedagogical advice, network meetings, educational support, psychological treatment, or no treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The child's impact of mental health problems reported by the parent on the Strengths and Difficulties Questionnaire Impact Scale.

    The parent-reported Strengths and Difficulties Questionnaire (SDQ) Impact Scale is scored from 0 to 10 (1, 2, 3, 4, 5, 6, 7, 8, 9, 10) with higher scores indicating more impact of mental health problems.

    The minimum relevant difference in impact of mental health problems measured by the SDQ Impact Scale was set at 1.0 corresponding to a change from severe to moderate, or from moderate to little-or-no impact in one of the five domains of child's life (distress, home-life, friendships, classroom learning and leisure activities). The SDQ Impact was previously measured at week 0, 2, 4, 6, 8, 10, 12, 14, 18 and 26 asking about the last six months at baseline and asking about the last month at each follow-up.

    Measured: Last month at 3-year follow-up

Secondary outcomes (4)
  1. Emotional and behavioral problems

    The SDQ contains 25 items, each scored on a 3-point Likert scale (0, 1, 2), and divided into five sub-scales measuring emotional problems, behavioral problems, hyperactivity, peer problems and pro-social behavior. The total difficulties scale consists of 20 items, and the sum is calculated (range 0-40) to measure the emotional and behavioral difficulties across the first four problem areas. Higher scores indicate more severity of problems. The parent-reported total difficulties score was measured at week 0, 18 and 26 asking about the last six months at baseline and asking about the last month at week 18 and 26.

    Measured: Last month at 3-year follow-up

  2. School attendance: proportion of school-days within the last 4 weeks, where the child is present (no illegal absence)

    Parent reported measures of different kinds of school absence

    Measured: Last four weeks at 3-year follow-up

  3. Child Health Utility instrument (CHU9D)

    The Child Health Utility instrument (CHU9D) measures the health-related quality of life (QoL) in nine domains. The measure is developed specifically for use among children and adolescents. The CHU9D has nine items with five levels of severity in the domains: worried, sad, pain, tired, annoyed, schoolwork/homework, sleep, daily routine and activities. The raw scores range from 9 to 35, with 9 indicating the highest possible QoL and 35 indicating the poorest QoL. The scores can be converted to utilities ranging 0-1 on the dead-full health QALY scale, using preference-based scoring algorithms. The CHU9D is a validated measure of health-related quality of life for use in youth mental health trials.

    The parent-reported CHU9D was previously measured at week 0, 18 and 26 asking about the present day.

    Measured: The present day at 3-year follow-up

  4. The Parental Stress Scale (PSS)

    The Parental Stress Scale (PSS) is a parent-reported questionnaire with 18 items, scored on a five-point scale (strongly disagree =1, disagree=2, disagree or agree=3, agree=4, strongly agree=5) for each of the eight positively and ten negatively worded items. The scores of the eight positive items are reversed when coding the PSS, and a single parental stress sum is calculated (range 0-72) with higher scores indicating more parental stress. The PSS measures the stress a parent experiences in the role functioning as parent. The instrument has been validated in Denmark.

    The PSS score was measured at week 0, 18 and 26 asking the parent of the present time (no explicit time frame)

    Measured: Present time at 3-year follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2021
  2. Study start22 Mar 2021
  3. Primary completion31 Aug 2021
  4. Study completion17 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
396 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04804917
Sponsor's protocol ID
MHSCRDenmark, F-61502-03-1
Acronym
MindMyMindFU
Status last verified
Mar 2023
First submitted
10 Mar 2021
Last updated
23 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The pseudonymous individual participant data can be made available to investigators for individual participant data meta-analyses that have been approved by independent review committees. The data access will be granted on a case-by-case basis by the principal investigator (Pia Jeppesen) after further approval by the nongovernmental organization Psykiatrifonden (who was responsible for the implementation of the MMM program in the municipalities and has the legal responsibility as the data controller for the Web-based data collection). Access will be granted to the extent permissible by the General Data Protection Regulation and the Danish Data Protection Act. Making the data available may require approval from the Danish Data Protection Authority.

Publications

  • Jeppesen P, Wolf RT, Nielsen SM, Christensen R, Plessen KJ, Bilenberg N, Thomsen PH, Thastum M, Neumer SP, Puggaard LB, Agner Pedersen MM, Pagsberg AK, Silverman WK, Correll CU. Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: A Randomized Clinical Trial. JAMA Psychiatry. 2021 Mar 1;78(3):250-260. doi: 10.1001/jamapsychiatry.2020.4045.

    PubMed 33355633
  • Wolf RT, Puggaard LB, Pedersen MMA, Pagsberg AK, Silverman WK, Correll CU, Plessen KJ, Neumer SP, Gyrd-Hansen D, Thastum M, Bilenberg N, Thomsen PH, Jeppesen P. Systematic identification and stratification of help-seeking school-aged youth with mental health problems: a novel approach to stage-based stepped-care. Eur Child Adolesc Psychiatry. 2022 May;31(5):781-793. doi: 10.1007/s00787-021-01718-5. Epub 2021 Jan 18.

    PubMed 33459884
  • Wolf RT, Ratcliffe J, Chen G, Jeppesen P. The longitudinal validity of proxy-reported CHU9D. Qual Life Res. 2021 Jun;30(6):1747-1756. doi: 10.1007/s11136-021-02774-9. Epub 2021 Feb 13.

    PubMed 33582966
  • Vassard D, Rimvall MK, Wolf RT, Christensen R, Nielsen SM, Plessen KJ, Verhulst F, Bilenberg N, Thomsen PH, Thastum M, Neumer SP, Pagsberg AK, Silverman WK, Correll CU, Jeppesen P. Outcome and cost-effectiveness of transdiagnostic cognitive behavioral therapy compared with management as usual for youth with common mental health problems: Long-term results from the Mind-My-Mind randomized trial. J Child Psychol Psychiatry. 2026 Aug;67(8):1307-1320. doi: 10.1111/jcpp.70128. Epub 2026 Mar 3.

    PubMed 41774040

Questions about this trial

What is this clinical trial studying?

An observational study of Emotional Problem and Anxiety Disorder of Childhood, run by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The child's impact of mental health problems reported by the parent on the Strengths and Difficulties Questionnaire Impact Scale. (time frame: Last month at 3-year follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04804917, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in